Literature DB >> 10964147

Comparison of intravenous patient-controlled analgesia with tramadol versus morphine after microvascular breast reconstruction.

M Silvasti1, N Svartling, M Pitkänen, P H Rosenberg.   

Abstract

Tramadol is a weak centrally acting analgesic and it might provide efficacious postoperative pain relief with minimal sedative effects in the use of intravenous patient-controlled analgesia (PCA). Sixty women scheduled to undergo microvascular breast reconstruction under standard general anaesthesia were enrolled in a study on the performance of patient-controlled analgesia with tramadol or morphine with special emphasis on drug- and technique-related side-effects. Seven patients were re-operated within the same day, leaving 25 patients in the tramadol group and 28 in the morphine group for comparison. When postoperative pain occurred, loading doses of either 10 mg tramadol or 1 mg morphine intravenous increments were administered in a double-blind fashion until the pain control was judged to be satisfactory by the patient. After that the patients received tramadol or morphine by a PCA apparatus (lockout 5 min, tramadol 450 microg kg-1, morphine 45 microg kg-1 bolus). In addition, all patients received 500 mg paracetamol rectally, three times a day. The potency ratio of tramadol to morphine was found to be between 8.5 : 1 (loading) and 11 : 1 (PCA). There was neither a significant difference between the groups in the overall satisfaction of the analgesic medication nor in the visual analogue and verbal rate scales for pain. Women in the tramadol group had more nausea and vomiting during the administration of loading doses (P < 0.05) and more patients in the tramadol group (7) than in the morphine group (3) (NS) wanted to discontinue the PCA therapy before the end of the study due to nausea. Sedation or blurred vision prevented the performance of the psychomotor tests in 22 and 32% of the tramadol and morphine patients, respectively. The remaining patients performed similarly in the Digit Symbol Substitution Test. In women receiving intravenous PCA for analgesia after microvascular breast reconstruction tramadol and morphine provided comparable postoperative analgesia with similar sedative effects. However, tramadol was associated with a disturbingly high incidence of nausea and vomiting.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10964147     DOI: 10.1046/j.1365-2346.2000.00710.x

Source DB:  PubMed          Journal:  Eur J Anaesthesiol        ISSN: 0265-0215            Impact factor:   4.330


  15 in total

Review 1.  Nausea and vomiting after surgery under general anesthesia: an evidence-based review concerning risk assessment, prevention, and treatment.

Authors:  Dirk Rüsch; Leopold H J Eberhart; Jan Wallenborn; Peter Kranke
Journal:  Dtsch Arztebl Int       Date:  2010-10-22       Impact factor: 5.594

Review 2.  Neuropsychological consequences of opiate use.

Authors:  Staci A Gruber; Marisa M Silveri; Deborah A Yurgelun-Todd
Journal:  Neuropsychol Rev       Date:  2007-08-10       Impact factor: 7.444

Review 3.  Patient-controlled analgesia in the management of postoperative pain.

Authors:  Mona Momeni; Manuela Crucitti; Marc De Kock
Journal:  Drugs       Date:  2006       Impact factor: 9.546

Review 4.  Clinical pharmacology of tramadol.

Authors:  Stefan Grond; Armin Sablotzki
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

5.  Reduced morphine consumption and pain intensity with local infiltration analgesia (LIA) following total knee arthroplasty.

Authors:  Per Essving; Kjell Axelsson; Jill Kjellberg; Orjan Wallgren; Anil Gupta; Anders Lundin
Journal:  Acta Orthop       Date:  2010-06       Impact factor: 3.717

6.  The Comparison of Intrathecal Morphine and IV Morphine PCA on Pain Control, Patient Satisfaction, Morphine Consumption, and Adverse Effects in Patients Undergoing Reduction Mammoplasty.

Authors:  Mehtap Karamese; Osman Akdağ; İnci Kara; Gokce Unal Yıldıran; Zekeriya Tosun
Journal:  Eplasty       Date:  2015-05-05

7.  Stability of tramadol with three 5-HT3 receptor antagonists in polyolefin bags for patient-controlled delivery systems.

Authors:  Fu-Chao Chen; Jun Zhu; Bin Li; Fang-Jun Yuan; Lin-Hai Wang
Journal:  Drug Des Devel Ther       Date:  2016-06-03       Impact factor: 4.162

8.  Efficacy and safety of Postoperative Intravenous Parecoxib sodium Followed by ORal CElecoxib (PIPFORCE) post-total knee arthroplasty in patients with osteoarthritis: a study protocol for a multicentre, double-blind, parallel-group trial.

Authors:  Qianyu Zhuang; Yanyan Bian; Wei Wang; Jingmei Jiang; Bin Feng; Tiezheng Sun; Jianhao Lin; Miaofeng Zhang; Shigui Yan; Bin Shen; Fuxing Pei; Xisheng Weng
Journal:  BMJ Open       Date:  2016-09-08       Impact factor: 2.692

9.  Going beyond efficacy: strategies for cancer pain management.

Authors:  J Myers; N Shetty
Journal:  Curr Oncol       Date:  2008-01       Impact factor: 3.677

Review 10.  Perioperative Blocks for Decreasing Postoperative Narcotics in Breast Reconstruction.

Authors:  Ariel Clare Johnson; Salih Colakoglu; Angela Reddy; Clara Marie Kerwin; Roland A Flores; Matthew L Iorio; David W Mathes
Journal:  Anesth Pain Med       Date:  2020-10-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.